Citations for
1AIMP2, SNCA
Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
Ham S, Yun SP, Kim H, Kim D, Seo BA, Kim H, Shin JY, Dar MA, Lee GH, Lee YI, Kim D, Kim S, Kweon HS, Shin JH, Ko HS, Lee Y.
Sci Transl Med. Nov 11;12(569):eaax0091. doi: 10.1126/scitranslmed.aax0091. 2020
2AIMP2
Single-cell analysis of AIMP2 splice variants informs on drug sensitivity and prognosis in hematologic cancer
Ku J, Kim R, Kim D, Kim D, Song S, Lee K, Lee N, Kim M, Yoon SS, Kwon NH, Kim S, Kim Y, Koh Y.
Commun Biol. Oct 30;3(1):630. doi: 10.1038/s42003-020-01353-x. 2020
3AIMP2, HLD17
Homozygosity for a nonsense variant in AIMP2 is associated with a progressive neurodevelopmental disorder with microcephaly, seizures, and spastic quadriparesis.
Shukla A, Das Bhowmik A, Hebbar M, Rajagopal KV, Girisha KM, Gupta N, Dalal A.
J Hum Genet. Jan;63(1):19-25. doi: 10.1038/s10038-017-0363-1. Epub 2017 Nov 16. 2018
4AIMP2
Purification and biophysical characterization of the AIMP2-DX2 protein.
Jha R, Cho HY, Mushtaq AU, Lee K, Kim DG, Kim S, Jeon YH.
Protein Expr Purif. Apr;132:131-137. doi: 10.1016/j.pep.2017.02.002. Epub 2017 Feb 7. 2017
5AIMP2, VPS35
VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
Yun SP, Kim H, Ham S, Kwon SH, Lee GH, Shin JH, Lee SH, Ko HS, Lee Y.
Cell Death Dis. Apr 6;8(4):e2741. doi: 10.1038/cddis.2017.157. 2017
6AIMP2
AIMP2 Controls Intestinal Stem Cell Compartments and Tumorigenesis by Modulating Wnt/β-Catenin Signaling
Yum MK, Kang JS, Lee AE, Jo YW, Seo JY, Kim HA, Kim YY, Seong J, Lee EB, Kim JH, Han JM, Kim S, Kong YY.
Cancer Res. Aug 1;76(15):4559-68. doi: 10.1158/0008-5472.CAN-15-3357. Epub 2016 Jun 4. 2016
7AIMP2
Structural switch of lysyl-tRNA synthetase between translation and transcription.
Ofir-Birin Y, Fang P, Bennett SP, Zhang HM, Wang J, Rachmin I, Shapiro R, Song J, Dagan A, Pozo J, Kim S, Marshall AG, Schimmel P, Yang XL, Nechushtan H, Razin E, Guo M.
Mol Cell. Jan 10;49(1):30-42. doi: 10.1016/j.molcel.2012.10.010. Epub 2012 Nov 15. 2013
8AIMP2
Splicing variant of AIMP2 as an effective target against chemoresistant ovarian cancer
Choi JW, Lee JW, Kim JK, Jeon HK, Choi JJ, Kim DG, Kim BG, Nam DH, Kim HJ, Yun SH, Kim S.
J Mol Cell Biol. Jun;4(3):164-73. doi: 10.1093/jmcb/mjs018. Epub 2012 Apr 24. 2012
9ABL1, AIMP2, FBP1, PRKN
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.
Ko HS, Lee Y, Shin JH, Karuppagounder SS, Gadad BS, Koleske AJ, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM.
Proc Natl Acad Sci U S A 107(38):16691-6. Epub 2010 Sep 7. 2010
10AIMP2
AIMP2/p38, the scaffold for the multi-tRNA synthetase complex, responds to genotoxic stresses via p53.
Han JM, Park BJ, Park SG, Oh YS, Choi SJ, Lee SW, Hwang SK, Chang SH, Cho MH, Kim S.
Proc Natl Acad Sci U S A 105(32):11206-11. Epub 2008 Aug 11. 2008
11AIMP2
Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers.
Park SG, Ewalt KL, Kim S.
Trends Biochem Sci 30(10):569-74. Review. 2005
12AIMP2, EPRS
Noncanonical function of glutamyl-prolyl-tRNA synthetase: gene-specific silencing of translation.
Sampath P, Mazumder B, Seshadri V, Gerber CA, Chavatte L, Kinter M, Ting SM, Dignam JD, Kim S, Driscoll DM, Fox PL.
Cell 119(2):195-208. 2004
13AIMP2, PMS2
Analysis of the 5' region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene.
Nicolaides NC, et al.
Genomics 29 : 329-334. 1995